132 related articles for article (PubMed ID: 15023079)
1. Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor.
Devanathan S; Yao Z; Salamon Z; Kobilka B; Tollin G
Biochemistry; 2004 Mar; 43(11):3280-8. PubMed ID: 15023079
[TBL] [Abstract][Full Text] [Related]
2. Different structural states of the proteolipid membrane are produced by ligand binding to the human delta-opioid receptor as shown by plasmon-waveguide resonance spectroscopy.
Alves ID; Cowell SM; Salamon Z; Devanathan S; Tollin G; Hruby VJ
Mol Pharmacol; 2004 May; 65(5):1248-57. PubMed ID: 15102953
[TBL] [Abstract][Full Text] [Related]
3. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
4. Optical anisotropy in lipid bilayer membranes: coupled plasmon-waveguide resonance measurements of molecular orientation, polarizability, and shape.
Salamon Z; Tollin G
Biophys J; 2001 Mar; 80(3):1557-67. PubMed ID: 11222316
[TBL] [Abstract][Full Text] [Related]
5. Ligand-specific interactions modulate kinetic, energetic, and mechanical properties of the human β2 adrenergic receptor.
Zocher M; Fung JJ; Kobilka BK; Müller DJ
Structure; 2012 Aug; 20(8):1391-402. PubMed ID: 22748765
[TBL] [Abstract][Full Text] [Related]
6. Influence of lipid composition on the structural stability of g-protein coupled receptor.
Mahmood I; Liu X; Neya S; Hoshino T
Chem Pharm Bull (Tokyo); 2013; 61(4):426-37. PubMed ID: 23546002
[TBL] [Abstract][Full Text] [Related]
7. Use of plasmon waveguide resonance (PWR) spectroscopy for examining binding, signaling and lipid domain partitioning of membrane proteins.
Hruby VJ; Alves I; Cowell S; Salamon Z; Tollin G
Life Sci; 2010 Apr; 86(15-16):569-74. PubMed ID: 19281827
[TBL] [Abstract][Full Text] [Related]
8. Plasmon-waveguide resonance and impedance spectroscopy studies of the interaction between penetratin and supported lipid bilayer membranes.
Salamon Z; Lindblom G; Tollin G
Biophys J; 2003 Mar; 84(3):1796-807. PubMed ID: 12609881
[TBL] [Abstract][Full Text] [Related]
9. Plasmon-waveguide resonance spectroscopy studies of lateral segregation in solid-supported proteolipid bilayers.
Salamon Z; Devanathan S; Tollin G
Methods Mol Biol; 2007; 398():159-78. PubMed ID: 18214380
[TBL] [Abstract][Full Text] [Related]
10. Binding of agonists, antagonists and inverse agonists to the human delta-opioid receptor produces distinctly different conformational states distinguishable by plasmon-waveguide resonance spectroscopy.
Salamon Z; Hruby VJ; Tollin G; Cowell S
J Pept Res; 2002 Dec; 60(6):322-8. PubMed ID: 12464110
[TBL] [Abstract][Full Text] [Related]
11. Study of G-Protein Coupled Receptor Signaling in Membrane Environment by Plasmon Waveguide Resonance.
Alves ID; Lecomte S
Acc Chem Res; 2019 Apr; 52(4):1059-1067. PubMed ID: 30865424
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
13. Coupled plasmon-waveguide resonators: a new spectroscopic tool for probing proteolipid film structure and properties.
Salamon Z; Macleod HA; Tollin G
Biophys J; 1997 Nov; 73(5):2791-7. PubMed ID: 9370473
[TBL] [Abstract][Full Text] [Related]
14. Coupled plasmon-waveguide resonance spectroscopy studies of the cytochrome b6f/plastocyanin system in supported lipid bilayer membranes.
Salamon Z; Huang D; Cramer WA; Tollin G
Biophys J; 1998 Oct; 75(4):1874-85. PubMed ID: 9746528
[TBL] [Abstract][Full Text] [Related]
15. Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.
Salamon Z; Cowell S; Varga E; Yamamura HI; Hruby VJ; Tollin G
Biophys J; 2000 Nov; 79(5):2463-74. PubMed ID: 11053123
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX.
West GM; Chien EY; Katritch V; Gatchalian J; Chalmers MJ; Stevens RC; Griffin PR
Structure; 2011 Oct; 19(10):1424-32. PubMed ID: 21889352
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric homogeneous method for identification of ligand binding to G protein-coupled receptors: receptor-ligand binding and β-arrestin assay.
Kopra K; Kainulainen M; Mikkonen P; Rozwandowicz-Jansen A; Hänninen P; Härmä H
Anal Chem; 2013 Feb; 85(4):2276-81. PubMed ID: 23330639
[TBL] [Abstract][Full Text] [Related]
18. Techniques: plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions.
Tollin G; Salamon Z; Hruby VJ
Trends Pharmacol Sci; 2003 Dec; 24(12):655-9. PubMed ID: 14654307
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
Gether U; Lin S; Kobilka BK
J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
